Published in Haematologica on January 17, 2014
Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2016) 0.80
Health-related quality of life after deep vein thrombosis. Springerplus (2016) 0.78
Assessment of the SF-36 version 2 in the United Kingdom. J Epidemiol Community Health (1999) 4.40
Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 2.50
Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost (2008) 1.67
Prospective evaluation of health-related quality of life in patients with deep venous thrombosis. Arch Intern Med (2005) 1.43
Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. Am J Health Syst Pharm (2006) 1.33
VEINES-QOL/Sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosis. J Clin Epidemiol (2006) 1.31
Post-thrombotic syndrome: prevalence, prognostication and need for progress. Br J Haematol (2009) 1.27
Measurement properties of the Villalta scale to define and classify the severity of the post-thrombotic syndrome. J Thromb Haemost (2009) 1.26
Incidence and cost burden of post-thrombotic syndrome. J Thromb Thrombolysis (2009) 1.18
The influence of venous thromboembolism on quality of life and severity of chronic venous disease. J Thromb Haemost (2004) 0.99
Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study. J Thromb Haemost (2012) 0.89
Measuring health-related quality of life in venous disease: practical and scientific considerations. Angiology (1997) 0.87
Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago. Thromb Res (2001) 0.86
Presenting D-dimer and early symptom severity are independent predictors for post-thrombotic syndrome following a first deep vein thrombosis. Br J Haematol (2013) 0.81
Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet (2002) 3.73
Virchow and his triad: a question of attribution. Br J Haematol (2008) 3.43
Training carers of stroke patients: randomised controlled trial. BMJ (2004) 2.95
Randomized controlled study of stroke unit care versus stroke team care in different stroke subtypes. Stroke (2002) 2.56
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes. Blood (2007) 2.37
Determinants of caregiving burden and quality of life in caregivers of stroke patients. Stroke (2005) 1.87
Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial. J Hepatol (2005) 1.79
Long-haul flights and deep vein thrombosis: a significant risk only when additional factors are also present. Br J Haematol (2002) 1.67
Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology (2006) 1.51
Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation. Liver Int (2013) 1.50
The emerging dental workforce: why dentistry? A quantitative study of final year dental students' views on their professional career. BMC Oral Health (2007) 1.50
Risk factors for venous thrombosis in the black population. Thromb Haemost (2003) 1.50
Acquisition of competence in paediatric ileocolonoscopy with virtual endoscopy training. J Pediatr Gastroenterol Nutr (2006) 1.47
Population pharmacokinetics of enoxaparin during the antenatal period. Circulation (2013) 1.41
Massive splenomegaly is associated with significant morbidity after laparoscopic splenectomy. Ann Surg (2003) 1.35
Acute sickle cell hepatopathy represents a potential contraindication for percutaneous liver biopsy. Blood (2002) 1.34
A randomized controlled trial of an enhanced balance training program to improve mobility and reduce falls in elderly patients. J Am Geriatr Soc (2003) 1.29
The effects of blood pressure reduction on cognitive function: a review of effects based on pooled data from clinical trials. J Hypertens (2006) 1.18
The 2013 British Menopause Society & Women's Health Concern recommendations on hormone replacement therapy. Menopause Int (2013) 1.17
Quality of life and survival prediction in terminal cancer patients: a multicenter study. Cancer (2004) 1.12
Relationship between three palliative care outcome scales. Health Qual Life Outcomes (2004) 1.10
The effects of dental anxiety and irregular attendance on referral for dental treatment under sedation within the National Health Service in London. Community Dent Oral Epidemiol (2010) 1.08
Venous thromboembolism and ethnicity. Br J Haematol (2009) 1.08
The relationship between patient characteristics and carer psychological status in home palliative cancer care. Support Care Cancer (2003) 1.04
UV-B is required for normal development of oil glands in Ocimum basilicum L. (sweet basil). Ann Bot (2002) 1.04
The current status of bridging anticoagulation. Br J Haematol (2013) 1.00
Use of the out-of-hours emergency dental service at two south-east London hospitals. BMC Oral Health (2009) 1.00
Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation. Inflamm Bowel Dis (2007) 1.00
Evaluation of a short-term group intervention for informal carers of patients attending a home palliative care service. J Pain Symptom Manage (2004) 0.94
Haemostasis and thrombosis in liver disease. Br J Haematol (2009) 0.91
Pregnancy loss and thrombophilia: the elusive link. Br J Haematol (2012) 0.89
Symptom severity in advanced cancer, assessed in two ethnic groups by interviews with bereaved family members and friends. J R Soc Med (2003) 0.88
Perioperative myocardial infarction in a patient receiving low-dose prothrombin complex concentrates. Thromb Haemost (2007) 0.85
Comprehensive VTE prevention program incorporating mandatory risk assessment reduces the incidence of hospital-associated thrombosis. Chest (2013) 0.84
Anticoagulating obese patients in the modern era. Br J Haematol (2011) 0.84
African-Caribbean ethnicity is associated with a hypercoagulable state as measured by thrombin generation. Blood Coagul Fibrinolysis (2013) 0.84
Venous thromboembolism in the black population. Arch Intern Med (2004) 0.83
Effects of folic acid supplementation on inflammatory and thrombogenic markers in chronic smokers. A randomised controlled trial. Thromb Res (2003) 0.83
Sleeping position, oxygen saturation and lung volume in convalescent, prematurely born infants. Arch Dis Child Fetal Neonatal Ed (2006) 0.82
The prevention of pregnancy-related venous thromboembolism. Br J Haematol (2014) 0.82
Detection of prothrombin gene polymorphism at position 20209 (PT20209C/T): pilot study in a black population in the United Kingdom. Thromb Haemost (2005) 0.81
Thyroid cancer and renal transplantation: a meta-analysis. Endocr Relat Cancer (2010) 0.81
Presenting D-dimer and early symptom severity are independent predictors for post-thrombotic syndrome following a first deep vein thrombosis. Br J Haematol (2013) 0.81
Is the gag reflex useful in the management of swallowing problems in acute stroke? Dysphagia (2005) 0.80
Is homozygosity for factor V Leiden a risk factor for myocardial infarction in young women who smoke? Thromb Haemost (2005) 0.79
Deep vein thrombosis and pulmonary embolism: diagnosis, treatment and prevention. Clin Med (2011) 0.79
Risk score predicting decline in renal function postliver transplant: role in patient selection for combined liver kidney transplantation. Transplantation (2010) 0.79
More on thromboprophylaxis: quantifying risk for venous thromboembolism. Thromb Haemost (2009) 0.78
Anticoagulation for prevention and treatment of cancer-related venous thromboembolism. Br J Haematol (2013) 0.78
Measurement of the direct oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in human plasma using turbulent flow liquid chromatography with high-resolution mass spectrometry. Ther Drug Monit (2014) 0.78
Does IgA antibody against β2 glycoprotein I increase cardiovascular risk in hemodialysis patients? Kidney Int (2012) 0.78
Tests for hereditary thrombophilia are of limited value in the black population. Stroke (2003) 0.77
Effect of Model Variables on in vitro Erosion. Caries Res (2015) 0.77
The MRC superficial bladder cancer trial of intravesical mytomicin-c after complete surgical resection. Sequential statistical methods applied to survival data from a randomised clinical trial. Int J Surg (2009) 0.76
Thrombolysis in pregnancy. Thromb Haemost (2003) 0.76
Does ethnicity matter? Bereavement outcomes in two ethnic groups living in the United Kingdom. Palliat Support Care (2005) 0.75
More on normal prothrombin times in the presence of therapeutic levels of rivaroxaban--early experience from King's College Hospital. Br J Haematol (2013) 0.75
Risk factors for cancer-associated venous thromboembolism in outpatient deep venous thrombosis clinics. Br J Haematol (2010) 0.75
An animal model of "syringe feel" during peripheral nerve block. Reg Anesth Pain Med (2009) 0.75
Acquired factor V inhibitor after haematopoietic stem cell transplantation. Thromb Haemost (2007) 0.75
New anticoagulants for prevention and treatment of venous thromboembolism. Curr Vasc Pharmacol (2010) 0.75
Heparin-induced skin necrosis. Br J Haematol (2005) 0.75
Extrinsic venous compression: a sufficient explanation for venous thromboembolism due to massive fibroids? Thromb Haemost (2006) 0.75
Ambulatory therapy of patients with free-floating proximal deep vein thrombosis is safe. Thromb Haemost (2005) 0.75
Late onset hypogonadism: an alternate cause for night sweats in the haematology clinic. Br J Haematol (2009) 0.75
Monitoring of florfenicol residues in fish muscle by HPLC-UV with confirmation of suspect results by LC-MS/MS. Drug Test Anal (2012) 0.75
Recurrent refractory arterial thromboembolism associated with the Janus kinase 2 V617F mutation. J Vasc Surg (2009) 0.75
Collaborative working to reduce VTE. Nurs Times (2012) 0.75
Normal prothrombin times in the presence of therapeutic levels of apixaban--in-vivo experience from King's College Hospital. Br J Haematol (2014) 0.75
Clinical Experience of Prescribing Dabigatran Etexilate With Dronedarone: The Role of Therapeutic Drug Monitoring. Ther Drug Monit (2016) 0.75
Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reporting. Thromb Haemost (2016) 0.75
Impact of venous thromboembolism on survival in patients with malignancy. Br J Haematol (2009) 0.75
Cytomegalovirus infection after liver transplantation: viral load as a guide to treating clinical infection. Transplantation (2002) 0.75
Coagulation factor levels and venous thrombosis in the black population. Thromb Haemost (2004) 0.75
Staff motivation to prevent venous thromboembolism. Br J Nurs (2012) 0.75
Nurses are key to ensuring that patients are assessed for VTE risk. Nurs Times (2009) 0.75
Sniff nasal inspiratory pressure in patients with moderate-to-severe chronic obstructive pulmonary disease: learning effect and short-term between-session repeatability. Respiration (2014) 0.75